■ 学術雑誌
|
原著
|
|
1.
|
Furuya Takefumi, Inoue Eisuke, Tanaka Eiichi, Yamanaka Hisashi, Harigai Masayoshi：
Prevalence of high and low serum alkaline phosphatase levels and the associated factors in patients with rheumatoid arthritis: results from the IORRA cohort study.
Modern rheumatology
：なし
, 2024.3
DOI:10.1093/mr/roae025
|
|
2.
|
Sugihara Takahiko, Kawahito Yutaka, Kaneko Yuko, Tanaka Eiichi, Yanai Ryo, Yajima Nobuyuki, Kojima Masayo, Harigai Masayoshi：
Systematic review for the treatment of older rheumatoid arthritis patients informing the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis.
Modern rheumatology
：なし
, 2024.3
DOI:10.1093/mr/roae026
|
|
3.
|
Sugano Eri, Sugitani Nohiro, Muronoi Mai, Inoue Eisuke, Tanaka Eiichi, Nakajima Ayako, Nishina Kumiko, Yamaguchi Rei, Moeko Ochiai, Ikari Katsunori, Yamanaka Hisashi, Sugimoto Naoki, HARIGAI MASAYOSHI*：
Unincreased mortality of patients with early rheumatoid arthritis compared to the general population in the past 17 years: Analyses from the IORRA cohort.
Modern Rheumatology
34
(2)
：322-328
, 2024.2
DOI:10.1093/mr/road020
|
|
4.
|
Bieber T, Feist E, Irvine AD, Harigai M, Haladyj E, Ball S, Deberdt W, Issa M, Grond S, Taylor PC：
Correction to: A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19.
Advances in Therapy
40
(9)
：4114-4115
, 2023.9
DOI:10.1007/s12325-023-02526-w. Epub
|
|
5.
|
Harigai Msayoshi, Tanaka Eiichi, Inoue Eisuke, Tamura Naoto, Misaki Kenta, Azuma Takanori, Hirata Shintaro, Hirano Fuminori, Taniguchi Yoshinori, Mitsuhash Masaki, Kondo Masahiro, Oribe Motohiro, Aoki Kazutosh, Kadode Michiaki , Tsuritani Katsuki, Yamanaka Hisashi：
Contribution of the factors to EuroQol 5 Dimensions in rheumatoid arthritis patients achieving low disease activity/remission with abatacept treatment: post-hoc subgroup analyses of the Japanese real-world observational "ORIGAMI" study.
Mod Rheumatol
：082
, 2023.8
DOI:10.1093/mr/road082
|
|
6.
|
Harigai M, Miyamae T, Hashimoto H, Yoshida A, Yamashita K, Nakaoka Y：
A multicentre, large-scale, observational study of tocilizumab in patients with Takayasu arteritis in Japan: The ACTEMRA® (ACT)-Bridge study.
Mod Rheumatol.
33
(5)
：998-1006
, 2023.8
DOI:10.1093/mr/roac099
|
|
7.
|
Harigai M, Miyamae T, Hashimoto H, Umetsu K, Yamashita K, Nakaoka：
A multicentre, large-scale, observational study of tocilizumab in patients with giant cell arteritis in Japan.
Mod Rheumatol
：074
, 2023.7
DOI:10.1093/mr/road074
|
|
8.
|
Higuchi T, Tanaka E, Inoue E, Abe M, Saka K, Sugano E, Sugitani N, Higuchi Y, Ochiai M, Yamaguchi R, Ikari K, Yamanaka H, Harigai M：
Evaluation of RABBIT risk score in Japanese patients with rheumatoid arthritis starting first bDMARDs: a validation study using the IORRA cohort data.
Mod Rheumatol
：066
, 2023.7
DOI:10.1093/mr/road066.
|
|
9.
|
Kuwana M, Sugiyama N, Momohara S, Atsumi T, Takei S, Tamura N, Harigai M, Fujii T, Matsuno H, Takeuchi T, Yamamoto K, Takasaki Y, Tanigawa M, Endo Y, Hirose T, Morishima Y, Yoshii N, Mimori T, Takagi M：
Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance.
Mod Rheumatol
：063
, 2023.7
DOI:10.1093/mr/road063
|
|
10.
|
Sada KE, Nagasaka K, Kaname S, Nango E, Kishibe K, Dobashi H, Hiromura K, Kawakami T, Bando M, Wada T, Amano K, Murakawa Y：
Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of microscopic polyangiitis and granulomatosis with polyangiitis: The 2023 update.
Mod Rheumatol
：081
, 2023.7
DOI:10.1093/mr/road081
|
|
11.
|
Sugano E, Tanaka E, Inoue E, Honda S, Abe M, Saka K, Sugitani N, Ochiai M, Yamaguchi R, Ikari K, Harigai M：
Impact of interstitial lung disease on clinical remission and unfavourable events of rheumatoid arthritis: results from the IORRA cohort.
Rheumatology
：317
, 2023.6
DOI:10.1093/rheumatology/kead317.
|
|
12.
|
Fujisaki M, Higuchi T, Konda N, Hirahara S, Watanabe K, Yamada R, Motoyama R, Yamaguchi R, Katsumata Y, Kawaguchi Y, Harigai M：
Development of microscopic polyangiitis following idiopathic plueroparenchymal fibroelastosis: a case report.
Mod Rheumatol Case Rep
：035
, 2023.6
DOI:10.1093/mrcr/rxad035. Online ahead of print.PMID: 37307430
|
|
13.
|
Sada KE, Nagasaka K, Kaname S, Higuchi T, Furuta S, Nanki T, Tsuboi N, Amano K, Dobashi H, Hiromura K, Bando M, Wada T, Arimura Y, Makino H, Harigai M：
Evaluation of Ministry of Health, Labour and Welfare diagnostic criteria for antineutrophil cytoplasmic antibody-associated vasculitis compared to ACR/EULAR 2022 classification criteria.
Mod Rheumatol
：052
, 2023.6
DOI:10.1093/mr/road052. Online ahead of print.PMID: 37279574
|
|
14.
|
Ichimura Yuki, Ikei Hiroyuki, Konishi Risa, Zeniya Moko, Okai Takahiro, Nomura Toshifumi, Negishi Kousuke, Okiyama Naoko：
Relevance of leukaemia inhibitory factor to anti-melanoma differentiation-associated gene 5 antibody-positive interstitial lung disease.
Rheumatology (Oxford, England)
62
(6)
：2267-2271
, 2023.6
DOI:10.1093/rheumatology/keac632
|
|
15.
|
Misaki K, Tamura N, Azuma T, Shinoda K, Tanaka M, Fujiwara H, Tsuboi H, Kasama T, Yoshimi R, Hanyu T, Kusaka Y, Hirao M, Onishi M, Uchino A, Izumiyama T, Yang KS, Ogawa N, Matsui K, Kurasawa K, Kawai S, Yasuoka H, Okumura N, Ueda Y, Tanaka E, Inoue E, Tsuritani K, Matsumoto S, Yamanaka H, Harigai M：
Associations of disease duration and anti-citrullinated peptide antibody status with the effectiveness of abatacept in biologic-naïve patients with rheumatoid arthritis: Post-hoc analysis of a multicentre, real-world observational study in Japan (ORIGAMI).
Mod Rheumatol
：045
, 2023.5
DOI:10.1093/mr/road045. Online ahead of print.PMID: 37233722
|
|
16.
|
Yeo AL, Kandane-Rathnayake R, Koelmeyer R, Golder V, Louthrenoo W, Chen YH, Cho J, Lateef A, Hamijoyo L, Luo SF, Wu YJ, Navarra SV, Zamora L, Li Z, An Y, Sockalingam S, Katsumata Y, Harigai M, Hao Y, Zhang Z, Basnayake BMDB, Chan M, Kikuchi J, Takeuchi T, Bae SC, Oon S, O'Neill S, Goldblatt F, Ng KPL, Law A, Tugnet N, Kumar S, Tee C, Tee M, Ohkubo N, Tanaka Y, Lau CS, Nikpour M, Hoi A, Leech M, Morand EF：
SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus - an analysis of anti-double-stranded DNA monitoring.
Rheumatology (Oxford)
：231
, 2023.5
DOI:10.1093/rheumatology/kead231
|
|
17.
|
Sugihara T, Yoshifuji H, Uchida HA, Maejima Y, Watanabe Y, Tanemoto K, Umezawa N, Manabe Y, Ishizaki J, Shirai T, Nagafuchi H, Hasegawa H, Niiro H, Ishii T, Nakaoka Y, Harigai M：
Establishing clinical remission criteria for giant cell arteritis: Results of a Delphi exercise carried out by an expert panel of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis.
Mod Rheumatol
：046
, 2023.5
DOI:10.1093/mr/road046
|
|
5件表示
|
|
全件表示(17件)
|
|
総説及び解説
|
|
1.
|
針谷正祥, 本田卓：
関節リウマチにおける骨破壊とポリジェニック・リスクファクターとの相関.
リウマチ科
69
(6)
：710-715
, 2023.6
DOI:0915-227X
|
|
2.
|
針谷正祥：
診療ガイドラインat a glance 関節リウマチ診療ガイドライン2020.
診療ガイドラインat a glance 関節リウマチ診療ガイドライン2020
112
(6)
：992-997
, 2023.6
DOI:0021-5384
|
|
症例報告
|
|
1.
|
Fujisaki Misako, Kasamatsu Hiroshi, Nishimura Kentarou, Yoshida Yasuyuki, Muneishi Yoriko, Yamaguchi Tomohisa, Nishino Ichizo, Konishi Risa, Ichimura Yuki, Okiyama Naoko, Oyama Noritaka, Hasegawa Minoru：
A case of anti-SAE1/2 antibody-positive dermatomyositis with extensive panniculitis: A possible cutaneous manifestation of treatment resistance.
The Journal of dermatology
51
(2)
：301-306
, 2024.2
DOI:10.1111/1346-8138.17000
|
|
2.
|
松田 薫, 楠目エマ, 山上淳, 石黒直子, 杉谷直大, 本山亮, 針谷正祥, 荒川直緒子, 桂秀樹, 多賀谷悦子：
COVID-19後に急速進行性間質性肺炎を伴う抗MDA5抗体陽性の皮膚筋炎を発症した1例.
日本皮膚科学会雑誌
133
(4)
：732
, 2023.4
|
|
ページの先頭へ
|
|
■ 学会発表
|
1.
|
ICHIMURA Yuki, KONISHI Risa, FUJIMOTO Manabu, NOMURA Toshifumi, OKIYAMA Naoko：
Interstitial lung disease based on autoimmunity against melanoma differentiation-associated gene 5.
International Societies for Investigative Dermatology Meeting 2023,
Tokyo,
2023/05
|
|
2.
|
◎中島亜矢子, 小嶋俊久, 福田亙, 吉尾卓, 天野宏一, 齊藤和義, 井上永介, 桃原茂樹, 蓑田清次, 石黒直樹, 田中良哉, 竹内勤, 山中寿：
生物学的製剤にて加療された関節リウマチ患者の生命予後は悪化しない.
第56回日本リウマチ学会総会・学術集会,
東京,
2023/04
|
|
3.
|
◎杉谷 直大, 田中 榮一, 井上 永介, 菅野 瑛梨, 仁科 久美子,針谷 正祥：
関節リウマチ患者の生命予後の検討:IORRAコホートを用いた検討.
第67回日本リウマチ学会総会・学術集会,
福岡国際会議場・福岡サンパレス・福岡国際センター,
2023/04
|
|
4.
|
◎杉谷直大, 針谷正祥, 田中榮一, 仁科久美子, 菅野瑛梨, 猪狩勝則：
高齢発症関節リウマチ患者の治療成績・有害事象発生の変化の検討:IORRAコホートを用いた検討.
第67回日本リウマチ学会総会・学術集会,
福岡国際会議場・福岡サンパレス・福岡国際センター,
2023/04
|
|
5.
|
◎菅野瑛梨, 田中榮一, 井上永介, 仁科久美子, 室野井麻衣, 杉谷直大, 落合萌子, 山口麗, 猪狩勝則, 針谷正祥：
D2T RA患者のアウトカムの検討-IORRAコホートを用いた検討.
第67回日本リウマチ学会総会・学術集会,
福岡国際会議場・福岡サンパレス・福岡国際センター,
2023/04
|
|
6.
|
◎室野井麻衣, 針谷正祥, 仁科久美子, 菅野瑛梨, 杉谷直大, 落合萌子, 山口麗, 樋口陽子, 田中榮一, 井上永介, 山中寿, 猪狩勝則：
血清反応陽性と陰性の高齢発症関節リウマチ患者における治療反応性の比較～IORRAコホートを用いた検討～.
第67回日本リウマチ学会総会・学術集会,
福岡国際会議場・福岡サンパレス・福岡国際センター,
2023/04
|
|
7.
|
◎布村多佳子, ◎岸崇之：
上司と部下でつくるリウマチ医ワークライフバランス2023.
第67回日本リウマチ学会総会・学術集会,
福岡,
2023/04
|
|
5件表示
|
|
全件表示(7件)
|
|
ページの先頭へ
|
|
